MAC Lung Disease clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
open to eligible people ages 18-85
This clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)
at UC Davis UCSF
Our lead scientists for MAC Lung Disease research studies include Scott Crabtree, MD Mohamed Fayed, MD, FCCP.
Last updated: